Articles that mention Sanofi -BoardProspects

Sanofi

0 Comments Leave a Comment

1-15 of 24 1 2 »
1. Mentioned In 24 Articles
2. Sigilon Therapeutics Appoints Veteran Biotech Industry Leader John Cox to Board of Directors
  
  Explore Yahoo! Finance May 7 2019 BoardMoves
  
  ...ficer of Bioverativ. In that role, Mr. Cox built, grew and led the company to an $11.6 billion acquisition by Sanofi, which was considered one of the most successful spinouts in biopharma history... ...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi acquisition MBA
3. Inovio Appoints Global Commercial Leader to its Board of Directors
  
  Explore MarketWatch Mar 25 2019 BoardMoves
  
  ...ing marketing career launching and building blockbuster products for Merck, Amgen, Eisai and Sanofi. While at Sanofi, she led the Sanofi Oncology Global Marketing function including its pipeline, launch, and life cycle m...
  Read Full Article
  
  Comment
  
  Mentions: Management Sanofi Amgen
4. Lilly CEO David Ricks Snags $17.2M Pay Package for 2018, a 9% Hike
  
  Explore Pharma News Mar 13 2019 BoardNews
  
  ...chief executive Richard Gonzalez pulled in $21 million last year as megablockbuster Humira continues to soar. Sanofi, working through some problems of its own, paid its helmsman Olivier Brandicourt $8.2 million last year...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi stock options David Ricks
5. Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare
  
  Explore Business Insider Dec 19 2018 BoardNews
  
  ... The companies claim they would have a joint market share that far exceeded rivals such as Johnson & Johnson, Sanofi, and Bayer. Integrating the two businesses should bring annual savings of £500m ($633 million) by 2022,...
  Read Full Article
  
  Comment
  
  Mentions: IPO Sanofi General Electric
6. Activist Investor Elliott Has Taken Position in Germany's Bayer
  
  Explore SHARENET Dec 7 2018 BoardNews
  
  ... unit, Elanco, formerly of Eli Lilly, unlisted Boehringer Ingelheim, which acquired animal health assets from Sanofi, and drugmaker Merck & Co. (Writing by Ludwig Burger Editing by Douglas Busvine and David Holmes) 2018-...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Investors Sanofi
7. Ready to Rumble, Ironwood? Activist Investor Alex Denner Suits up for Board-Seat Bid
  
  Explore Pharma News Apr 10 2018 BoardNews
  
  ...opharma companies over the last few years, including Ariad and Aegerion. Most recently, he helped orchestrate Sanofi’s $11.6 billion Bioverativ buy, which redeemed the French drugmaker after failed plays for Medivation a...
  Read Full Article
  
  Comment
  
  Mentions: Management IPO Wells Fargo
8. Activist Alex Denner to Gain Board Control at Medicines Company
  
  Explore CNBC.com Mar 1 2018 BoardNews
  
  ...red with Sanofi. Early sales have disappointed, though some key data are expected this month on Regeneron and Sanofi's drug, Praluent, that investors hope could spur sales. Inclisiran is designed to have to be injected l...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Carl Icahn Amgen
9. L’Oreal CEO Says Cosmetics Maker Ready to Buy Nestle's Stake - Bloomberg
  
  Explore Bloomberg Feb 9 2018 BoardNews
  
  ... L’Oreal’s founding family, in September. L’Oreal has 1.8 billion euros in cash and owns a 9 percent stake in Sanofi. “If it was not enough, we got love letters from lots of great banks telling us they would love to lend...
  Read Full Article
  
  Comment
  
  Mentions: Investors Sanofi Nestle
10. Sanofi is Buying Another Blood-Disease Biotech for $4.8 Billion
  
  Explore Business Insider Jan 29 2018 BoardNews
  
  ...would boost long-term value for its shareholders, while the takeover was expected to have a neutral impact on Sanofi's business earnings per share (EPS) in 2018 and 2019. Sanofi is already one of Ablynx's big pharma part...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi acquisition Morgan Stanley
11. ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors
  
  Explore businesswire.com Jan 24 2018 BoardMoves
  
  ...duct, Kadcyla®, and in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. More information about the Company can be found at www.immunogen.com. Kalydeco®, Orkambi®, ...
  Read Full Article
  
  Comment
  
  Mentions: Investors Sanofi Nasdaq
12. Acerus Appoints Mr. Mark Lievonen to its Board of Directors
  
  Explore businesswire.com Dec 7 2017 BoardMoves
  
  ...ceutical industry, more recently as the President of Sanofi Pasteur Limited, the Canadian vaccine division of Sanofi, a global pharmaceutical company. He is a Director of Oncolytics Biotech Inc., Quest PharmaTech Inc., a...
  Read Full Article
  
  Comment
  
  Mentions: Audit Committee Sanofi Twitter
13. PerkinElmer Elects Pascale Witz to its Board of Directors
  
  Explore businesswire.com Oct 30 2017 BoardMoves
  
  ...st recently serving as executive vice president, Global Diabetes and Cardiovascular for Sanofi, S.A. Prior to Sanofi, she held several leadership positions during her 17 years with GE Healthcare, including the role of pr...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi MBA Pascale Witz
14. L'Oreal Advances on Prospect of Sale of Nestle's Holding
  
  Explore Bloomberg Sep 22 2017 BoardNews
  
  ...not the right time to make any further comment.” L’Oreal could sell its 9.4 percent stake in French drugmaker Sanofi to finance a repurchase of Nestle’s stake, according to Pierre Tegner, an analyst at Natixis. A judge i...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Takeover Sale
15. Nestle: Overseas Activism Has Overhangs
  
  Explore Stock Market News & Financial Analysis Jun 29 2017 BoardNews
  
  ...t would take some work for L'Oreal, but there are options - raising debt, using cash and possibly selling its Sanofi stake. The move would be a positive for Nestle, providing cash for buybacks and acquisitions, as well b...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Governance Investors Sanofi
16. How Third Point's Nestlé Assault Makes L'Oréal Worth It
  
  Explore Home Jun 27 2017 BoardBlogs
  
  ... pledged to do, it would have almost €10bn of firepower. It could add €10bn by selling its stake in drugmaker Sanofi. Buying and cancelling the shares would add about 15 per cent to L'Oréal's earnings per share, says RBC...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Hedge Fund Sanofi
17. 1-15 of 24 1 2 »